Close Menu

NEW YORK – IGeneX, a maker of tick-borne disease tests, announced yesterday its immunoblot assays for tick-borne relapsing fever have been approved by the Division of Laboratories of the Department of Health of the State of New York. The assays are now immediately available to New York practitioners.

The Tick-Borne Relapsing Fever (TBRF) ImmunoBlots (IgM and IgG) detect antibodies to Borrelia species, including B. hermsii, B. miyamotoi, and B. turicatae.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.